MACC1 and ovarian serous adenocarcinoma: In the search for potential novel biomarkers for early detection and disease management [17], we here show, for the first time, the successful lentiviral integration of shRNA targeting MACC1 into the genome of two high-grade serous ovarian cancer organoid lines.